rediff.com
e.g. Tata motors, Reliance MF, 500570
Tatva Chintan Pharma Chem Ltd. - Research Center
543321 TATVA Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 378.68 403.04 427.81 291.19 253.84
Expenses
Material consumed 185.73 239.15 209.49 151.79 135.80
Manufacturing expenses 34.78 23.61 22.62 9.92 8.96
Personnel expenses 54.76 38.60 30.81 24.13 20.53
Selling expenses - - - - -
Adminstrative expenses 36.54 47.01 59.12 40.16 36.16
Expenses capitalised - - - - -
Cost of sales 311.81 348.37 322.04 226.00 201.45
Operating profit 66.87 54.68 105.77 65.19 52.39
Other recurring income 7.51 5.68 10.51 5.10 0.56
Adjusted PBDIT 74.37 60.36 116.28 70.29 52.95
Financial expenses 6.51 8.38 4.83 4.21 3.94
Depreciation 25.60 9.55 8.18 6.73 4.79
Other write offs - - - - -
Adjusted PBT 42.27 42.42 103.27 59.35 44.22
Tax charges 12.92 -1.63 7.28 7.99 9.25
Adjusted PAT 29.35 44.05 95.99 51.36 34.96
Non recurring items - -3.59 - - -
Other non cash adjustments - - - - -
Reported net profit 29.35 40.47 95.99 51.36 34.96
Earnigs before appropriation 303.26 278.34 237.88 157.97 106.61
Equity dividend 4.68 4.43 - 4.02 -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 298.58 273.91 237.88 153.95 106.61
Close
Add Tatva Chintan Pharma Chem Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Tatva Chintan Pharma Chem Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close